Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Bi-Specific Antibodies Market Growth (Status and Outlook) 2022-2028

  • LP 4893881
  • 64 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Bi-Specific Antibodies will have significant change from previous year. According to our (LP Information) latest study, the global Bi-Specific Antibodies market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bi-Specific Antibodies market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Bi-Specific Antibodies market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bi-Specific Antibodies market, reaching US$ million by the year 2028. As for the Europe Bi-Specific Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Bi-Specific Antibodies players cover Roche (Chugai), Amgen, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Bi-Specific Antibodies market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Fragment-Based Antibodies

IgG-Based Antibodies

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Cancer

Haemophilia

Other Non-Cancer Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Roche (Chugai)

Amgen

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bi-Specific Antibodies Market Size 2017-2028

2.1.2 Bi-Specific Antibodies Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Bi-Specific Antibodies Segment by Type

2.2.1 Fragment-Based Antibodies

2.2.2 IgG-Based Antibodies

2.3 Bi-Specific Antibodies Market Size by Type

2.3.1 Bi-Specific Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)

2.4 Bi-Specific Antibodies Segment by Application

2.4.1 Cancer

2.4.2 Haemophilia

2.4.3 Other Non-Cancer Diseases

2.5 Bi-Specific Antibodies Market Size by Application

2.5.1 Bi-Specific Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)

3 Bi-Specific Antibodies Market Size by Player

3.1 Bi-Specific Antibodies Market Size Market Share by Players

3.1.1 Global Bi-Specific Antibodies Revenue by Players (2020-2022)

3.1.2 Global Bi-Specific Antibodies Revenue Market Share by Players (2020-2022)

3.2 Global Bi-Specific Antibodies Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Bi-Specific Antibodies by Regions

4.1 Bi-Specific Antibodies Market Size by Regions (2017-2022)

4.2 Americas Bi-Specific Antibodies Market Size Growth (2017-2022)

4.3 APAC Bi-Specific Antibodies Market Size Growth (2017-2022)

4.4 Europe Bi-Specific Antibodies Market Size Growth (2017-2022)

4.5 Middle East & Africa Bi-Specific Antibodies Market Size Growth (2017-2022)

5 Americas

5.1 Americas Bi-Specific Antibodies Market Size by Country (2017-2022)

5.2 Americas Bi-Specific Antibodies Market Size by Type (2017-2022)

5.3 Americas Bi-Specific Antibodies Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bi-Specific Antibodies Market Size by Region (2017-2022)

6.2 APAC Bi-Specific Antibodies Market Size by Type (2017-2022)

6.3 APAC Bi-Specific Antibodies Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Bi-Specific Antibodies by Country (2017-2022)

7.2 Europe Bi-Specific Antibodies Market Size by Type (2017-2022)

7.3 Europe Bi-Specific Antibodies Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bi-Specific Antibodies by Region (2017-2022)

8.2 Middle East & Africa Bi-Specific Antibodies Market Size by Type (2017-2022)

8.3 Middle East & Africa Bi-Specific Antibodies Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Bi-Specific Antibodies Market Forecast

10.1 Global Bi-Specific Antibodies Forecast by Regions (2023-2028)

10.1.1 Global Bi-Specific Antibodies Forecast by Regions (2023-2028)

10.1.2 Americas Bi-Specific Antibodies Forecast

10.1.3 APAC Bi-Specific Antibodies Forecast

10.1.4 Europe Bi-Specific Antibodies Forecast

10.1.5 Middle East & Africa Bi-Specific Antibodies Forecast

10.2 Americas Bi-Specific Antibodies Forecast by Country (2023-2028)

10.2.1 United States Bi-Specific Antibodies Market Forecast

10.2.2 Canada Bi-Specific Antibodies Market Forecast

10.2.3 Mexico Bi-Specific Antibodies Market Forecast

10.2.4 Brazil Bi-Specific Antibodies Market Forecast

10.3 APAC Bi-Specific Antibodies Forecast by Region (2023-2028)

10.3.1 China Bi-Specific Antibodies Market Forecast

10.3.2 Japan Bi-Specific Antibodies Market Forecast

10.3.3 Korea Bi-Specific Antibodies Market Forecast

10.3.4 Southeast Asia Bi-Specific Antibodies Market Forecast

10.3.5 India Bi-Specific Antibodies Market Forecast

10.3.6 Australia Bi-Specific Antibodies Market Forecast

10.4 Europe Bi-Specific Antibodies Forecast by Country (2023-2028)

10.4.1 Germany Bi-Specific Antibodies Market Forecast

10.4.2 France Bi-Specific Antibodies Market Forecast

10.4.3 UK Bi-Specific Antibodies Market Forecast

10.4.4 Italy Bi-Specific Antibodies Market Forecast

10.4.5 Russia Bi-Specific Antibodies Market Forecast

10.5 Middle East & Africa Bi-Specific Antibodies Forecast by Region (2023-2028)

10.5.1 Egypt Bi-Specific Antibodies Market Forecast

10.5.2 South Africa Bi-Specific Antibodies Market Forecast

10.5.3 Israel Bi-Specific Antibodies Market Forecast

10.5.4 Turkey Bi-Specific Antibodies Market Forecast

10.5.5 GCC Countries Bi-Specific Antibodies Market Forecast

10.6 Global Bi-Specific Antibodies Forecast by Type (2023-2028)

10.7 Global Bi-Specific Antibodies Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche (Chugai)

11.1.1 Roche (Chugai) Company Information

11.1.2 Roche (Chugai) Bi-Specific Antibodies Product Offered

11.1.3 Roche (Chugai) Bi-Specific Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche (Chugai) Main Business Overview

11.1.5 Roche (Chugai) Latest Developments

11.2 Amgen

11.2.1 Amgen Company Information

11.2.2 Amgen Bi-Specific Antibodies Product Offered

11.2.3 Amgen Bi-Specific Antibodies Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Amgen Main Business Overview

11.2.5 Amgen Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Bi-Specific Antibodies Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Fragment-Based Antibodies

Table 3. Major Players of IgG-Based Antibodies

Table 4. Bi-Specific Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)

Table 7. Bi-Specific Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)

Table 10. Global Bi-Specific Antibodies Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Bi-Specific Antibodies Revenue Market Share by Player (2020-2022)

Table 12. Bi-Specific Antibodies Key Players Head office and Products Offered

Table 13. Bi-Specific Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Bi-Specific Antibodies Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Bi-Specific Antibodies Market Size Market Share by Regions (2017-2022)

Table 18. Americas Bi-Specific Antibodies Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Bi-Specific Antibodies Market Size Market Share by Country (2017-2022)

Table 20. Americas Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)

Table 22. Americas Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)

Table 24. APAC Bi-Specific Antibodies Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Bi-Specific Antibodies Market Size Market Share by Region (2017-2022)

Table 26. APAC Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)

Table 28. APAC Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)

Table 30. Europe Bi-Specific Antibodies Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Bi-Specific Antibodies Market Size Market Share by Country (2017-2022)

Table 32. Europe Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)

Table 34. Europe Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Bi-Specific Antibodies Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Bi-Specific Antibodies

Table 43. Key Market Challenges & Risks of Bi-Specific Antibodies

Table 44. Key Industry Trends of Bi-Specific Antibodies

Table 45. Global Bi-Specific Antibodies Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Bi-Specific Antibodies Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Bi-Specific Antibodies Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Bi-Specific Antibodies Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Bi-Specific Antibodies Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Bi-Specific Antibodies Market Size Market Share Forecast by Application (2023-2028)

Table 51. Roche (Chugai) Details, Company Type, Bi-Specific Antibodies Area Served and Its Competitors

Table 52. Roche (Chugai) Bi-Specific Antibodies Product Offered

Table 53. Roche (Chugai) Bi-Specific Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Roche (Chugai) Main Business

Table 55. Roche (Chugai) Latest Developments

Table 56. Amgen Details, Company Type, Bi-Specific Antibodies Area Served and Its Competitors

Table 57. Amgen Bi-Specific Antibodies Product Offered

Table 58. Amgen Main Business

Table 59. Amgen Bi-Specific Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Amgen Latest Developments

List of Figures

Figure 1. Bi-Specific Antibodies Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Bi-Specific Antibodies Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Bi-Specific Antibodies Market Size Market Share by Type in 2021

Figure 7. Bi-Specific Antibodies in Cancer

Figure 8. Global Bi-Specific Antibodies Market: Cancer (2017-2022) & ($ Millions)

Figure 9. Bi-Specific Antibodies in Haemophilia

Figure 10. Global Bi-Specific Antibodies Market: Haemophilia (2017-2022) & ($ Millions)

Figure 11. Bi-Specific Antibodies in Other Non-Cancer Diseases

Figure 12. Global Bi-Specific Antibodies Market: Other Non-Cancer Diseases (2017-2022) & ($ Millions)

Figure 13. Global Bi-Specific Antibodies Market Size Market Share by Application in 2021

Figure 14. Global Bi-Specific Antibodies Revenue Market Share by Player in 2021

Figure 15. Global Bi-Specific Antibodies Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)

Figure 17. APAC Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)

Figure 18. Europe Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)

Figure 20. Americas Bi-Specific Antibodies Value Market Share by Country in 2021

Figure 21. Americas Bi-Specific Antibodies Consumption Market Share by Type in 2021

Figure 22. Americas Bi-Specific Antibodies Market Size Market Share by Application in 2021

Figure 23. United States Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Bi-Specific Antibodies Market Size Market Share by Region in 2021

Figure 28. APAC Bi-Specific Antibodies Market Size Market Share by Application in 2021

Figure 29. China Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Bi-Specific Antibodies Market Size Market Share by Country in 2021

Figure 36. Europe Bi-Specific Antibodies Market Size Market Share by Type in 2021

Figure 37. Europe Bi-Specific Antibodies Market Size Market Share by Application in 2021

Figure 38. Germany Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Application in 2021

Figure 46. Egypt Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 52. APAC Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 53. Europe Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 55. United States Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 56. Canada Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 59. China Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 60. Japan Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 61. Korea Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 63. India Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 64. Australia Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 65. Germany Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 66. France Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 67. UK Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 68. Italy Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 69. Russia Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 70. Spain Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 73. Israel Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390